InvestorsHub Logo
Followers 0
Posts 12
Boards Moderated 0
Alias Born 10/30/2015

Re: stugwins post# 553

Thursday, 11/17/2016 8:30:38 AM

Thursday, November 17, 2016 8:30:38 AM

Post# of 592
"Who knows what Biogen and the other companies have in mind! They may have a great product that only needs the resolution of a viscosity problem but the core of their product is covered by some other IP. Does this even matter to EGRX? "

That's exactly what Eagles plans are.
Work with partners and license their technology to them to resolve the viscosity problem.
The partners will pay for all clinical trials.
Eagle would receive upfront, milestone and royalty payments.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EGRX News